VIBATIV Pregnancy Registry

The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance

NCT01187719 ·Status: COMPLETED ·Phase: PHASE2

A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies

NCT00000942 ·Status: COMPLETED ·Phase: PHASE3

Single Dose Pharmacokinetics of Doravirine in HIV-infected Pregnant Women

NCT04900974 ·Status: COMPLETED ·Phase: PHASE1

Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission

NCT00021671 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

NCT01618305 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women

NCT00006320 ·Status: COMPLETED ·Phase: PHASE1

Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine

NCT00000828 ·Status: COMPLETED

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.

NCT00404989 ·Status: RECRUITING

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

NCT04518228 ·Status: COMPLETED

Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery

NCT00540605 ·Status: COMPLETED ·Phase: PHASE1

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

NCT06336434 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

NCT00109590 ·Status: COMPLETED ·Phase: PHASE2

A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children

NCT00001106 ·Status: COMPLETED ·Phase: PHASE1

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

NCT01854762 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women

NCT00017797 ·Status: COMPLETED

A Study of HIV Levels During Pregnancy and After Childbirth

NCT00041964 ·Status: COMPLETED

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

NCT00017719 ·Status: COMPLETED ·Phase: PHASE3

Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection

NCT02778204 ·Status: COMPLETED ·Phase: PHASE1

Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP

NCT00204308 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

NCT00038480 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters

NCT01251601 ·Status: WITHDRAWN

Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)

NCT00334256 ·Status: COMPLETED ·Phase: PHASE2

Pre-Exposure Prophylaxis Dosing in Pregnancy to Optimize HIV Prevention (PREP-P)

NCT03834909 ·Status: WITHDRAWN ·Phase: PHASE1

A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

NCT00000887 ·Status: COMPLETED ·Phase: PHASE1

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

NCT00086359 ·Status: COMPLETED ·Phase: PHASE3